SevenRooms Acquires HeyPluto
Cooley and co-counsel Dixon Law advised SevenRooms, a marketing and operations platform for the hospitality industry, on its acquisition of HeyPluto, an artificial intelligence Short Message Service marketing platform used by hospitality and consumer brands to build and sustain authentic and mutually profitable relationships with their customers. SevenRooms Acquires HeyPluto
Payapps to Be Acquired by Autodesk
Cooley advised Payapps and its private equity sponsor IFM Investors on a definitive agreement in which Payapps will be acquired by Autodesk, a multinational software company listed as ADSK on Nasdaq. Payapps is cloud-based construction software for submitting, assessing and approving progress payments for main contractors and subcontractors. Payapps to […]
Yieldstreet Completes Acquisition of Cadre
Cooley advised Yieldstreet, a leading private market investing platform, on its acquisition of Cadre, an online real estate-focused investment platform that serves institutional and high net worth investors. Yieldstreet Completes Acquisition of Cadre
PSI Group Plans Nasdaq Listing Through Merger With AIB Acquisition Corporation
Cooley advised PSI Group Holdings, a long-established global logistics service provider headquartered in Hong Kong offering cross-border air freight services, as its US legal counsel on its definitive agreement to combine with AIB Acquisition Corporation, a publicly traded special purpose acquisition company. PSI Group Plans Nasdaq Listing Through Merger With […]
MadCap Software Acquires Xyleme
Cooley advised MadCap Software, a multichannel content authoring, management and publishing solutions provider, on its acquisition of Xyleme, which offers intelligent content management for the development, control, delivery, and syndication of vital proprietary learning and development content across the enterprise. MadCap Software Acquires Xylem
Cooley Advises Lantheus on Concurrent PIPE Investment, Partnering Transaction, Asset Sale With Perspective Therapeutics
Cooley advised Lantheus Holdings (LNTH on Nasdaq) on its strategic transactions with Perspective Therapeutics (CATX on NYSE American), which consists of an agreement to purchase up to a 19.99% stake in Perspective through a private investment in public equity (PIPE) transaction, Perspective’s grant to Lantheus of options to exclusively license […]
Gracell Biotechnologies to be Acquired by AstraZeneca for up to Approximately $1.2 Billion
Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for the treatment of cancer and autoimmune diseases, on its definitive agreement to be acquired by AstraZeneca. Gracell Biotechnologies to be Acquired by AstraZeneca for up to Approximately $1.2 Billion
RayzeBio Signs Approximately $4.1 Billion Acquisition Agreement With Bristol Myers Squibb
Cooley advised RayzeBio, a clinical-stage radiopharmaceutical therapeutics (RPT) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs, on its definitive agreement to be acquired by Bristol Myers Squibb. RayzeBio Signs Approximately $4.1 Billion Acquisition Agreement With Bristol Myers Squibb
HealthTrio Combines With mPulse and Decision Point Healthcare Solutions
Cooley advised HealthTrio, a top provider of comprehensive health management and member engagement solutions, on its strategic acquisition by mPulse, which also announced its acquisition of Decision Point Healthcare Solutions. HealthTrio Combines With mPulse and Decision Point Healthcare Solutions
Carmot Therapeutics Enters Definitive Merger Agreement With Roche
Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes, on its definitive merger agreement pursuant to which Roche will acquire Carmot. Carmot Therapeutics Enters Definitive Merger Agreement With Roche